Work

Reviewer #1 (Public Review): CTLA-4 antibody-drug conjugate reveals autologous destruction of B-lymphocytes associated with regulatory T cell impairment

Year: 2023

Type: peer-review

Source: eLife

DOI: 10.7554/elife.87281.1.sa2

Language: English

Topic: T-cell and B-cell Immunology

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,500

Funders: National Institutes of Health, National Institute of Allergy and Infectious Diseases

Award: Preserving CTLA-4 immune checkpoint for safer and more effective cancer immunotherapy

OpenAlex ID: W4368377821

Cites: 22

Cited by:

Related to: 10